Dementia clinical trial implications of mild behavioral impairment.
|Title||Dementia clinical trial implications of mild behavioral impairment.|
|Publication Type||Journal Article|
|Year of Publication||2018|
|Authors||Mortby ME, Black SE, Gauthier S, Miller D, Porsteinsson A, Smith EE, Ismail Z|
|Date Published||2018 Feb|
The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.
|Alternate Journal||Int Psychogeriatr|